Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 7 » default
Therapeutics and Clinical Risk Management
ISSN: 1178-203X
- View all (2241)
- Volume 19, 2023 (24)
- Volume 18, 2022 (104)
- Volume 17, 2021 (134)
- Volume 16, 2020 (134)
- Volume 15, 2019 (154)
- Volume 14, 2018 (271)
- Volume 13, 2017 (188)
- Volume 12, 2016 (217)
- Volume 11, 2015 (210)
- Volume 10, 2014 (113)
- Volume 9, 2013 (57)
- Volume 8, 2012 (47)
- Volume 7, 2011 (59)
- Volume 6, 2010 (66)
- Volume 5, 2009 (102)
- Volume 4, 2008 (148)
- Volume 3, 2007 (126)
- Volume 2, 2006 (47)
- Volume 1, 2005 (40)
Archive: Volume 7, 2011
Update of a comparative analysis of cost minimization following the introduction of newly available intravenous iron therapies in hospital practice
Bhandari S
Therapeutics and Clinical Risk Management 2011, 7:501-509
Published Date: 12 December 2011
The effect of hyoscine butylbromide in shortening the first stage of labor: A double blind, randomized, controlled, clinical trial
Al Qahtani NH, Al Hajeri F
Therapeutics and Clinical Risk Management 2011, 7:495-500
Published Date: 8 December 2011
Emerging patient safety issues under health care reform: follow-on biologics and immunogenicity
Liang BA, Mackey T
Therapeutics and Clinical Risk Management 2011, 7:489-493
Published Date: 7 December 2011
Critical appraisal of ticagrelor in the management of acute coronary syndrome
Nawarskas JJ, Snowden SS
Therapeutics and Clinical Risk Management 2011, 7:473-488
Published Date: 5 December 2011
Zofenopril and incidence of cough: a review of published and unpublished data
Omboni S, Borghi C
Therapeutics and Clinical Risk Management 2011, 7:459-471
Published Date: 29 November 2011
Optimal management of Barrett's esophagus: pharmacologic, endoscopic, and surgical interventions
Konda VJA, Dalal K
Therapeutics and Clinical Risk Management 2011, 7:447-458
Published Date: 22 November 2011
Correlation between lamivudine plasma concentrations and patient self-reported adherence to antiretroviral treatment in experienced HIV patients
Minzi OM, Mugoyela V, Gustafsson LL
Therapeutics and Clinical Risk Management 2011, 7:441-446
Published Date: 22 November 2011
New antiangiogenics in non-small cell lung cancer treatment: Vargatef™ (BIBF 1120) and beyond
Gori B, Ricciardi S, Fulvi A, Intagliata S, Del Signore E, de Marinis F
Therapeutics and Clinical Risk Management 2011, 7:429-440
Published Date: 17 November 2011
Role of iron supplementation in promoting maternal and fetal outcome
Yekta Z, Pourali R, Mladkova N, Ghasemi-rad M , Boromand F, Hazrati Tappeh K
Therapeutics and Clinical Risk Management 2011, 7:421-428
Published Date: 31 October 2011
Patient reported outcome data following influenza A (H1N1p) vaccination in the 2009–2010 season: web-based and telephone evaluation
Wade AG, Crawford GM, Pumford N, McConnachie A
Therapeutics and Clinical Risk Management 2011, 7:409-420
Published Date: 21 October 2011
Critical appraisal of pralatrexate in the management of difficult-to-treat peripheral T cell lymphoma
Casanova M, Medina-Pérez A, Moreno-Beltran M, Mata-Vazquez M, Rueda A
Therapeutics and Clinical Risk Management 2011, 7:401-408
Published Date: 7 October 2011
Topical nonsteroidal anti-inflammatory drugs for management of osteoarthritis in long-term care patients
Argoff CE, Gloth FM
Therapeutics and Clinical Risk Management 2011, 7:393-399
Published Date: 20 September 2011
Cancer patient-centered home care: a new model for health care in oncology
Tralongo P, Ferraù F, Borsellino N, Verderame F, Caruso M, Giuffrida D, Butera A, Gebbia V
Therapeutics and Clinical Risk Management 2011, 7:387-392
Published Date: 9 September 2011
Critical appraisal of the use of alpha lipoic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathy
McIlduff CE, Rutkove SB
Therapeutics and Clinical Risk Management 2011, 7:377-385
Published Date: 5 September 2011
Treatment options for refractory and difficult to treat seizures: focus on vigabatrin
Tolman JA, Faulkner MA
Therapeutics and Clinical Risk Management 2011, 7:367-375
Published Date: 1 September 2011
The effect of a physician-targeted intervention on metoclopramide prescribing practice
Yang YX, Leonard CE, Freeman C, Hennessy S
Therapeutics and Clinical Risk Management 2011, 7:359-365
Published Date: 22 August 2011
Profile of ciclesonide for the maintenance treatment of asthma
Singas E, Karpel JP
Therapeutics and Clinical Risk Management 2011, 7:351-358
Published Date: 19 August 2011
Serum sodium disorders in patients with traumatic brain injury
Paiva WS, Bezerra DA, Amorim RL, Figueiredo EG, Tavares WM, De Andrade AF, Teixeira MJ
Therapeutics and Clinical Risk Management 2011, 7:345-349
Published Date: 11 August 2011
Pharmacovigilance analysis of adverse event reports for aliskiren hemifumarate, a first-in-class direct renin inhibitor
Ali AK
Therapeutics and Clinical Risk Management 2011, 7:337-344
Published Date: 9 August 2011
Effect of age on semen parameters in infertile men after varicocelectomy
Hassanzadeh-Nokashty K, Yavarikia P, Ghaffari A, Hazhir S, Hassanzadeh M
Therapeutics and Clinical Risk Management 2011, 7:333-336
Published Date: 9 August 2011
Role of carglumic acid in the treatment of acute hyperammonemia due to N-acetylglutamate synthase deficiency
Häberle J
Therapeutics and Clinical Risk Management 2011, 7:327-332
Published Date: 2 August 2011
Treatment of acute otitis externa with ciprofloxacin otic 0.2% antibiotic ear solution
Mösges R, Nematian-Samani M, Eichel A
Therapeutics and Clinical Risk Management 2011, 7:325-326
Published Date: 27 July 2011
Current and emerging treatments for the management of myasthenia gravis
Sathasivam S
Therapeutics and Clinical Risk Management 2011, 7:313-323
Published Date: 22 July 2011
Prolonged-release melatonin for insomnia – an open-label long-term study of efficacy, safety, and withdrawal
Lemoine P, Garfinkel D, Laudon M, Nir T, Zisapel N
Therapeutics and Clinical Risk Management 2011, 7:301-311
Published Date: 26 July 2011
Dexmedetomidine hydrochloride as a long-term sedative
Kunisawa T
Therapeutics and Clinical Risk Management 2011, 7:291-299
Published Date: 11 July 2011
Demonstration of an online tool to assist managed care formulary evidence-based decision making: meta-analysis of topical prostaglandin analog efficacy
Kymes SM, Burk C, Feinman T, Williams JM, Hollander DA
Therapeutics and Clinical Risk Management 2011, 7:283-290
Published Date: 12 July 2011
Seven years’ experience with etidronate in a woman with anorexia nervosa and vertebral fractures
Iwamoto J, Sato Y, Uzawa M, Takeda T, Matsumoto H
Therapeutics and Clinical Risk Management 2011, 7:275-281
Published Date: 5 July 2011
Conestat alfa for the treatment of angioedema attacks
Davis B, Bernstein JA
Therapeutics and Clinical Risk Management 2011, 7:265-273
Published Date: 1 July 2011
Three-year experience with combined treatment with alendronate and alfacalcidol in Japanese patients with severe bone loss and osteoporotic fracture
Iwamoto J, Sato Y, Uzawa M, Takeda T, Matsumoto H
Therapeutics and Clinical Risk Management 2011, 7:257-264
Published Date: 29 June 2011
Propofol-based deep sedation for endoscopic retrograde cholangiopancreatography procedure in sick elderly patients in a developing country
Amornyotin S, Kachintorn U, Chalayonnawin W, Kongphlay S
Therapeutics and Clinical Risk Management 2011, 7:251-255
Published Date: 27 June 2011
Clinical potential of lurasidone in the management of schizophrenia
Samalin L, Garnier M, Llorca PM
Therapeutics and Clinical Risk Management 2011, 7:239-250
Published Date: 27 June 2011
Naftopidil for the treatment of urinary symptoms in patients with benign prostatic hyperplasia
Masumori N
Therapeutics and Clinical Risk Management 2011, 7:227-238
Published Date: 23 June 2011
New form of administering chlorhexidine for treatment of denture-induced stomatitis
Ryalat S, Darwish R, Amin W
Therapeutics and Clinical Risk Management 2011, 7:219-225
Published Date: 14 June 2011
Dealing with thrombocytopenia during anticoagulation with heparins for active venous thromboembolism: a play-it-safe practical approach
Abdel-Razeq H, Ismael Y
Therapeutics and Clinical Risk Management 2011, 7:213-217
Published Date: 14 June 2011
Diclofenac gel in the treatment of actinic keratoses
Nelson CG
Therapeutics and Clinical Risk Management 2011, 7:207-211
Published Date: 15 June 2011
Effects of recombinant growth hormone (GH) replacement and psychomotor and cognitive stimulation in the neurodevelopment of GH-deficient (GHD) children with cerebral palsy: a pilot study
Devesa J, Alonso B, Casteleiro N, Couto P, Castañón B, Zas E, Reimunde P
Therapeutics and Clinical Risk Management 2011, 7:199-206
Published Date: 30 May 2011
If you don't take it – it can't work: the consequences of not being treated or nonadherence to osteoporosis therapy
Adachi JD, Josse RG, Russell RG
Therapeutics and Clinical Risk Management 2011, 7:181-198
Published Date: 24 May 2011
Accidental ingestion of BiTine ring and a note on inefficient ring separation forceps
Baghele ON, Baghele MO
Therapeutics and Clinical Risk Management 2011, 7:173-179
Published Date: 24 May 2011
Steroid response pattern and outcome of pediatric idiopathic nephrotic syndrome: a single-center experience in northwest Iran
Mortazavi F, Soleimani Khiavi Y
Therapeutics and Clinical Risk Management 2011, 7:167-171
Published Date: 27 May 2011
Fracture risk associated with continuation versus discontinuation of bisphosphonates after 5 years of therapy in patients with primary osteoporosis: a systematic review and meta-analysis
Fraser LA, Vogt KN, Adachi JD, Thabane L
Therapeutics and Clinical Risk Management 2011, 7:157-166
Published Date: 9 May 2011
Quantifying the impact of nonadherence patterns on exposure to oral immunosuppressants
Maclean JR, Pfister M, Zhou Z, Roy A, Tuomari VA, Heifets M
Therapeutics and Clinical Risk Management 2011, 7:149-156
Published Date: 11 April 2011
Gynecomastia – evaluation and current treatment options
Murad MH, Johnson RE, Kermott CA
Therapeutics and Clinical Risk Management 2011, 7:145-148
Published Date: 28 March 2011
Atrial fibrillation and the use of oral bisphosphonates
Michael Pazianas, Cyrus Cooper, Yiting Wang, et al
Therapeutics and Clinical Risk Management 2011, 7:131-144
Published Date: 22 March 2011
Management of Huntington’s disease: role of tetrabenazine
Marina de Tommaso, Claudia Serpino, Vittorio Sciruicchio
Therapeutics and Clinical Risk Management 2011, 7:123-129
Published Date: 21 March 2011
Broadening the use of antiretroviral therapy: the case for feline leukemia virus
Willie M Greggs III, Christine L Clouser, Steven E Patterson, et al
Therapeutics and Clinical Risk Management 2011, 7:115-122
Published Date: 16 March 2011
A hospital-based cost minimization study of the potential financial impact on the UK health care system of introduction of iron isomaltoside 1000
Sunil Bhandari
Therapeutics and Clinical Risk Management 2011, 7:103-113
Published Date: 15 March 2011
Inferior vena cava filters in cancer patients: to filter or not to filter
Hikmat Abdel-Razeq, Asem Mansour, Yousef Ismael, et al
Therapeutics and Clinical Risk Management 2011, 7:99-102
Published Date: 10 March 2011
A causative link between periodontal disease and glomerulonephritis: a preliminary study
Mohammad Reza Ardalan, Kamyar Ghabili, Reza Pourabbas, et al
Therapeutics and Clinical Risk Management 2011, 7:93-98
Published Date: 8 March 2011
Pharmacological and clinical overview of cloperastine in treatment of cough
Maria Antonietta Catania, Salvatore Cuzzocrea
Therapeutics and Clinical Risk Management 2011, 7:83-92
Published Date: 7 March 2011
Enzyme replacement therapy for Fabry disease: some answers but more questions
Majid Alfadhel, Sandra Sirrs
Therapeutics and Clinical Risk Management 2011, 7:69-82
Published Date: 25 February 2011
A new Web-based medical tool for assessment and prevention of comprehensive cardiovascular risk
Daniele Franchi, Davide Cini, Giorgio Iervasi
Therapeutics and Clinical Risk Management 2011, 7:59-68
Published Date: 17 February 2011
Anorexia nervosa versus hyperinsulinism: therapeutic effects of neuropharmacological manipulation
Fuad Lechin, Bertha van der Dijs, Betty Pardey-Maldonado, et al
Therapeutics and Clinical Risk Management 2011, 7:53-58
Published Date: 17 February 2011
Genitourinary system trauma after 2003 Bam earthquake in Kerman, Iran
Mohammad Hasan Dehghani Firoozabadi, Mehdi Abedinzadeh, Mohammad Kazem Moslemi
Therapeutics and Clinical Risk Management 2011, 7:49-52
Published Date: 9 February 2011
Pirfenidone treatment of idiopathic pulmonary fibrosis
Ye Gan, Erica L Herzog, Richard H Gomer
Therapeutics and Clinical Risk Management 2011, 7:39-47
Published Date: 8 February 2011
Paroxysmal atrial fibrillation in cryptogenic stroke
Neha S Dangayach, Kevin Kane, Majaz Moonis
Therapeutics and Clinical Risk Management 2011, 7:33-37
Published Date: 28 January 2011
The lupus band test in systemic lupus erythematosus patients
Adam Reich, Katarzyna Marcinow, Rafal Bialynicki-Birula
Therapeutics and Clinical Risk Management 2011, 7:27-32
Published Date: 24 January 2011
Investigation of pulmonary infection pathogens in neurological intensive care unit
Fengying Quan, Guangwei Liu, Liang Wang, et al
Therapeutics and Clinical Risk Management 2011, 7:21-25
Published Date: 21 January 2011
Economic considerations of antifungal prophylaxis in patients undergoing surgical procedures
Maria Adriana Cataldo, Nicola Petrosillo
Therapeutics and Clinical Risk Management 2011, 7:13-20
Published Date: 13 January 2011
Role of rituximab in first-line treatment of chronic lymphocytic leukemia
Jeffrey Bryan, Gautam Borthakur
Therapeutics and Clinical Risk Management 2011, 7:1-11
Published Date: 22 December 2010